Vy Dang Karp, PharmD, BCSCP Optum Infusion Services | Eunjung Kim, PharmD, BCSCP Optum Infusion Services | Lisa Schrade, PharmD Optum Infusion Services | Nidhi Thaker-Mehta, PharmD Optum Infusion Services
Hemophilia is an X-linked recessive coagulation disorder which is characterized by factor VIII deficiency.
Julia K. Nguyen, PharmD Kaiser Permanente, Southern California Home Infusion Pharmacy | Rulin Hechter, MD, PhD, MS Kaiser Permanente, Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science | Deborah
Claire Meredith, PharmD, CarepathRx | Leita Frey, PharmD, BCPS, CarepathRx, | Shelby George, PharmD, CarepathRx | Megan K. Zielke, PharmD, BCCCP, CarepathRx
Vancomycin is widely used to treat gram-positive infections. Vancomycin therapy is accompanied by the clinical monitoring of trough levels in order to maintain
Danell Haines, PhD, Research Consultant
Home infusion is a site of care (SOC) option for patients requiring intravenous (IV) or subcutaneous (SC) medications for treatment of acute and chronic medical conditions.
Jennifer Zhao, Johns Hopkins Care at Home; Brian Sherman, RN, Johns Hopkins Care at Home; Ashley McCracken, PharmD, MBA, Johns Hopkins Care at Home; Stephanie Watkins, RN, Johns Hopkins Care at Home; Kristopher Rusinko, PharmD, PhD, MBA, MEd, MS, Johns Hopkins Care at Home
A
Nicholas Panchak, PharmD, University of Minnesota Medical Center Fairview Health Services; Ryan McFarland, PharmD, University of Minnesota-Duluth College of Pharmacy; Jessica Das, PharmD, BCPS, Fairview Health Services; Alicia Zagel, PhD, MPH, Fairview Health Services; Jennifer Ross, PharmD, BCIDP, University of Minnesota Medical Center Fairview
The Foundation has adopted the Poster Session at the NHIA Annual Conference as part of its efforts to advance NHIF’s mission of promoting investigator-initiated research related to home and alternate infusion. NHIF awards a $1000 scholarship to a poster that exemplifies an innovative approach
Kassie Klasen, PharmD Fairview Pharmacy Services; Alicia Zagel, PhD, MPH Fairview Pharmacy Services; Mary Nelson, PharmD Fairview Pharmacy Services; Eric Betzold, MS Fairview Pharmacy Services; Brett Benfield, PharmD, MS, FNHIA Fairview Pharmacy Services
Health disparities have been exacerbated during the COVID-19 pandemic
Amy Mulgrew, RN, CRNI, IgCN, VA-BC, Advanced Infusion Care; Ashley McKenna, RN, IgCN, Advanced Infusion Care; Erin Mullis, RN, IgCN, Advanced Infusion Care
A literature review was conducted to evaluate the comparative rate of effectiveness, treatment failure due to adverse event (ADE), patient satisfaction, antimicrobial stewardship concerns,
Daniel Decker, PharmD, MBA, BCACP, Option Care Health
A literature review was conducted to evaluate the comparative rate of effectiveness, treatment failure due to adverse event (ADE), patient satisfaction, antimicrobial stewardship concerns, and potential cost comparisons of daptomycin and vancomycin.
Rohae Musa, PharmD, Option Care Health; Maria Giannakos, PharmD, MBA, BCPS, BCSCP, Option Care Health; Suzanne Kluge, B.S. Pharm, MBA, RPh, BCSCP, FNHIA, Option Care Health
The study assessed the safety of natalizumab administration by comparing outcomes after receiving natalizumab infusions at home vs. infusion
Danell Haines, PhD, Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA
Determine the home infusion pharmacist’s time commitment to tasks involved with onboarding a home infusion patient.
Sofia Shrestha, PharmD, CSP, Fairview Home Infusion; Dana Simonson, PharmD, BCPS, Fairview Pharmacy Services; Alicia Zagel, PhD, MPH, Fairview Pharmacy Services
Measure the incidence and severity of infusion-related reactions in patients receiving ocrelizumab administered in both hospital-based and outpatient sites of care.
Danell Haines, PhD Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA
NHIF retrospectively collected and analyzed data from the REGEN-COV patient charts. Data analysis showed that home infused REGENCOV achieved comparable outcomes to other sites of care and provided improved access to treatment.
Mark Wiencek, PhD, Contec, Inc.; Michael Bedenbaugh, PharmD, MBA, MS, Intramed Plus, Inc.; Lauren Pernot, BS, Contec, Inc.; Kate Douglass, MS, RN; Cognitive Design Associates
It is best practice to wipe down surfaces of supplies such as intravenous (IV) bags and vials packaged in cardboard boxes with
Cheyenne Johnson, PharmD, Option Care Health; Daniel Decker, PharmD, MBA, BCACP, Option Care Health; Maria Giannakos, PharmD, MBA, BCPS, BCSCP, Option Care Health
Patients treated with intravenous (IV) vancomycin in the hospital often require outpatient parenteral antimicrobial therapy (OPAT) after discharge for the continuation of therapy. Despite
Danell Haines, PhD, Research Consultant; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA
Patients in the 65+ age group and those receiving outpatient parenteral antimicrobial therapy (OPAT) in the home setting are increasing. There is a void in research that investigates OPAT satisfaction and outcomes
Danell Haines, PhD, Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA
Pharmacist professional services are paramount to the success of the home infusion process. Using home infusion pharmacist time utilization data collected in this study,
